Highlight Therapeutics: Funding, Investors & Team (Sep 2026)
Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology.
Highlight Therapeutics has raised $44.7M across 2 funding rounds on record, the most recent an undisclosed round of $17.7M announced in Sep 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Highlight Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Highlight Therapeutics Funding Rounds
Highlight Therapeutics raised $27.0M in an undisclosed round announced in Feb 2021.
4.6 years later, an undisclosed round of $17.7M was announced in Sep 2025.
Highlight Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Highlight Therapeutics Funding Compared to Other Biotechnology Startups
Highlight Therapeutics' latest round of $17.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Highlight Therapeutics in Biotechnology and Paterna
Companies Similar to Highlight Therapeutics
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Highlight Therapeutics Funding FAQs
What does Highlight Therapeutics do?
Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology.
How much funding has Highlight Therapeutics raised?
Highlight Therapeutics has raised $44.7M across 2 rounds on record. The most recent is an undisclosed round of $17.7M announced in Sep 2025.
When did Highlight Therapeutics last raise funding?
Highlight Therapeutics' most recent funding round on record is an undisclosed round of $17.7M, announced in Sep 2025.
Who is the CEO of Highlight Therapeutics?
Marisol Quintero is listed as CEO at Highlight Therapeutics.
Where is Highlight Therapeutics headquartered?
Highlight Therapeutics is based in Paterna, Comunidad Valenciana, Spain.
How many employees does Highlight Therapeutics have?
Highlight Therapeutics is in the 11-50 employee band.
How does Highlight Therapeutics' funding compare to other Biotechnology startups?
Highlight Therapeutics' latest round of $17.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Highlight Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Highlight Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.